Literature DB >> 33038682

Online recovery support meetings can help mitigate the public health consequences of COVID-19 for individuals with substance use disorder.

Brandon G Bergman1, John F Kelly2, Maurizio Fava3, A Eden Evins4.   

Abstract

For people with current and remitted substance use disorder (SUD), the COVID-19 pandemic increases risk for symptom exacerbation and relapse through added stressors and reduced service access. In response, mutual-help groups and recovery community organizations have increased access to online recovery support meetings. However, rigorous studies examining online recovery support meeting participation to inform best practices have not yet been conducted. In the absence of such studies, a review of relevant literature, considered in context of potential barriers and drawbacks, suggests the risk-to-benefit ratio is favorable. Particularly given limited in-person SUD service access resulting from COVID-19 precautions, online recovery support meetings may help mitigate a key public health problem during an ongoing, public health pandemic.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Covid-19; Digital recovery support services; Mutual-help organizations; Telemedicine

Year:  2020        PMID: 33038682      PMCID: PMC7493730          DOI: 10.1016/j.addbeh.2020.106661

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


Introduction

The COVID-19 pandemic carries particular risk for individuals with current and remitted substance use disorder (SUD). Beyond direct risks of contracting COVID-19 that may be elevated (Volkow, 2020), these individuals are also at risk for SUD symptom exacerbation or relapse via increased negative affect and life stressors. Social distancing-related closures, while in line with public health guidelines, have also disrupted SUD treatment and recovery support service access for these individuals when they need it most. The confluence of these indirect risks for millions with current and remitted SUD makes reduced service access a key public health issue during an ongoing, public health pandemic. Participation in mutual-help organizations (MHOs), such as Alcoholics Anonymous (AA) and SMART Recovery, is the most common form of SUD help-seeking in the US (Grant et al., 2015, Grant et al., 2016, Kelly et al., 2017). In response to service reductions caused by social distancing closures, local AA and other 12-step MHOs have migrated their meetings to online video platforms. Also, recovery community organizations have banded together to offer online recovery support meetings for individuals recovery with an array of recovery pathways (e.g., 12-step, secular, and medication-assisted). While access to in-person, empirically-supported SUD services is declining, access AA to online recovery support meetings, which had already extended the reach of in-person resources (Bergman, Greene, Hoeppner, & Kelly, 2018), is rapidly expanding. In the absence of rigorous studies that can directly inform clinical and public health recommendations, a brief review of relevant literature, in context of barriers and potential drawbacks, suggests the risk-to-benefit ratio of participation in these free, digital recovery support services is favorable.

Online recovery support meetings are likely to mobilize the same therapeutic mechanisms as empirically-supported, in-person MHOs

Twelve-step MHO participation improves substance use outcomes for individuals with alcohol use disorder and stimulant use disorder, as well as opioid use disorder after receiving, or in tandem with, opioid agonist medications like buprenorphine and methadone (Kelly et al., 2020, Weiss et al., 2005, Weiss et al., 2019). AA participation, specifically, promotes these better outcomes by enhancing a) recovery-supportive social network changes, such as adding supportive individuals to, and dropping risky individuals from, one’s network, b) coping skills, c) abstinence self-efficacy, and d) abstinence motivation (Kelly, 2017). These mechanisms of behavior change are consistent with theorized targets of other psychosocial approaches including cognitive-behavioral therapies (Larimer, Palmer, & Marlatt, 1999). Pending more rigorous research, existing data also suggests MHO participation in secular (i.e., non-12-step) groups like SMART Recovery may be associated with benefits similar to 12-step MHOs (Zemore, Lui, Mericle, Hemberg, & Kaskutas, 2018). One might also hypothesize secular MHOs mobilize mechanisms similar to AA, given the overlap among different MHOs in their most core therapeutic elements (e.g., shared experience, social support, etc.). Like in-person groups, online recovery support meeting participation could help boost coping, self-efficacy, and motivation through combinations of new information and ideas, ready access to active support, and peer-based vicarious learning. Online recovery support meetings may also offer opportunities for adaptive social network changes, albeit to a lesser extent than in-person groups.

SUD telemedicine is an empirically-supported alternative to in-person interventions

The US Department of Health and Human Services is actively supporting and encouraging the use of telemedicine in response to COVID-19 social distancing precautions. SUD telemedicine generally produces substance use outcomes that rival those of in-person therapy for individuals with alcohol use disorder, as well as individuals with opioid use disorder when provided with opioid agonist medication (Lin et al., 2019). The fact that SUD telemedicine is a viable alternative to empirically-supported in-person SUD treatment analogs, suggests that online recovery support meetings are also likely to be viable alternatives to their empirically-supported, in-person MHO analogs.

Barriers to engagement and drawbacks of participation can be partially addressed

Data suggesting MHO participation is associated with better substance use outcomes are balanced by data suggesting there may be participation barriers for key groups. Individuals with non-abstinence goals (Zemore, Kaskutas, Mericle, & Hemberg, 2017), those with drug use disorder who are new to treatment (Humphreys, Barreto, & Alessi, 2020), and those taking agonist medication (Monico et al., 2015) may experience more challenges engaging with 12-step MHOs. These individuals may experience similar challenges engaging with online 12-step MHO meetings. While the availability of online groups that cater to specific populations (e.g., Medication Assisted Recovery Anonymous; MARA) may offset, in part, these limitations, they are not as widespread as online 12-step MHO meetings and may be more difficult to locate. Additional drawbacks, including risks, to online recovery support meeting participation are important to mention. First, while evidence shows SUD telemedicine is an effective alternative to in-person interventions (Lin et al., 2019), which suggests online recovery support meetings may be an effective alternative to in-person MHOs, more research is needed on SUD telemedicine in its own right. Also, in light of emerging data that group telemedicine for psychiatric disorders, more generally, may be less likely than in-person group therapy to promote positive alliance (Simpson & Reid, 2014), it is possible that the positive effects of SUD telemedicine may not translate to online recovery support meetings. In situations where individuals may only have access to online digital SUD services, however, the positive SUD telemedicine data are informative. Second, privacy breaches could occur if another individual observes a participant’s screen, for example, or if online platforms themselves collect or share data from participants. Breaches from indirect observation are difficult to address, though privacy risks can be partially managed through participation only on encrypted platforms and ensuring the host is taking advantage of privacy options (e.g., requiring a password and host permission to enter the meeting). Lastly, broadband internet access continues to divide individuals along socioeconomic lines (Pew Research Center, 2019). For those who lack access to broadband internet needed for online video streaming, referral to meetings accessible by telephone is an available option.

Summary

The COVID-19 pandemic puts people with current and remitted SUD at increased risk for symptom exacerbation and relapse through added stressors and reduced service access. Critically, individuals can adhere to public health guidelines for social distancing by physical distancing while engaging with ongoing social support and connection via free, online recovery support meetings. Given the potential benefits, in context of barriers and risks that may be partially addressed, we believe the risk-to-benefit ratio of online recovery support meeting participation is favorable. Particularly during this time of limited access to empirically-supported SUD services, online recovery support meetings may help address COVID-19-related risks and thereby mitigate the overall public health burden of this pandemic.

Contributors

Dr. Bergman conceptualized the commentary and wrote the initial draft, while Drs. Bergman, Kelly, and Evins each helped write and edit the manuscript. Dr. Fava provided key feedback to enhance commentary implications as pertaining to the field of clinical psychiatry. All authors contributed to, and have approved, the final manuscript.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
  10 in total

1.  Correspondence: Potential Benefits of Online Recovery Services for Women During and After COVID-19.

Authors:  Sara E Miller; Hannah B Apsley; Marci Cross-Ramirez
Journal:  J Stud Alcohol Drugs       Date:  2021-11       Impact factor: 2.582

2.  Real-World Reductions in Healthcare Resource Utilization over 6 Months in Patients with Substance Use Disorders Treated with a Prescription Digital Therapeutic.

Authors:  Neel Shah; Fulton F Velez; Samuel Colman; Laura Kauffman; Charles Ruetsch; Kathryn Anastassopoulos; Yuri Maricich
Journal:  Adv Ther       Date:  2022-07-12       Impact factor: 4.070

3.  Mixed methods prospective findings of the initial effects of the U.S. COVID-19 pandemic on individuals in recovery from substance use disorder.

Authors:  Katherine Shircliff; Melissa Liu; Christiana Prestigiacomo; Melissa Fry; Kevin Ladd; Misty Kannapel Gilbert; Mary Jo Rattermann; Melissa A Cyders
Journal:  PLoS One       Date:  2022-07-01       Impact factor: 3.752

4.  Gender differences in lifetime and current use of online support for recovery from alcohol use disorder.

Authors:  Paul A Gilbert; Elizabeth Saathoff; Alex M Russell; Grant Brown
Journal:  Alcohol Clin Exp Res       Date:  2022-06-19       Impact factor: 3.928

5.  Online support for all: Examining participant characteristics, engagement, and perceived benefits of an online harm reduction, abstinence, and moderation focused support group for alcohol and other drugs.

Authors:  Frank J Schwebel; Daniel G Orban
Journal:  Psychol Addict Behav       Date:  2022-03-10

6.  Predictors and outcomes of online mutual-help group attendance in a national survey study.

Authors:  Christine Timko; Amy Mericle; Lee Ann Kaskutas; Priscilla Martinez; Sarah E Zemore
Journal:  J Subst Abuse Treat       Date:  2022-02-08

7.  Nonfatal opioid overdoses before and after Covid-19: Regional variation in rates of change.

Authors:  Albert J Burgess-Hull; Kirsten E Smith; Leigh V Panlilio; Destiny Schriefer; Kenzie L Preston; Aliese Alter; Christopher Yeager; Timothy Chizmar; Ted Delbridge; Kenan Zamore; Jeff Beeson; David H Epstein
Journal:  PLoS One       Date:  2022-03-09       Impact factor: 3.240

8.  Using qualitative, community-based input to steer post-coronavirus disease 2019 pharmacy practice in substance use.

Authors:  Lucas Kosobuski; Andrew Hawn; Katelyn France; Nathaniel Chen; Cierra LaPlante; Laura Palombi
Journal:  J Am Pharm Assoc (2003)       Date:  2022-03-19

9.  Client perspectives on the accessibility and quality of substance use treatment during the COVID-19 pandemic.

Authors:  Randolph D Hubach; Andrew M O'Neil; Campbell Ernst; Mollie Stowe; Mark Hickey; Molly Remondino; Zachary Giano
Journal:  Drug Alcohol Depend Rep       Date:  2021-11-22

10.  Factors Associated With Increased Opioid Use During the COVID-19 Pandemic: A Prospective Study of Patients Enrolled in Opioid Agonist Treatment.

Authors:  Tea Rosic; Leen Naji; Nitika Sanger; David C Marsh; Andrew Worster; Lehana Thabane; Zainab Samaan
Journal:  J Addict Med       Date:  2021-11-16       Impact factor: 4.647

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.